title: [Arsenic trioxide for the treatment of medium and advanced primary liver cancer].
authors.affiliation: PLA Cancer Center of the 81st hospital, Nanjing 210002, China.
authors.forename: Jun
authors.initials: J
authors.lastname: Qian
authors.forename: Shukui
authors.initials: S
authors.lastname: Qin
authors.forename: Zeming
authors.initials: Z
authors.lastname: He
authors.forename: Lin
authors.initials: L
authors.lastname: Wang
authors.forename: Yingxia
authors.initials: Y
authors.lastname: Chen
authors.forename: Zhijian
authors.initials: Z
authors.lastname: Shao
authors.forename: Xiufeng
authors.initials: X
authors.lastname: Liu
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000009:adverse effects / Q000627:therapeutic use*; D056486:Chemical and Drug Induced Liver Injury; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010087:Oxides / Q000009:adverse effects / Q000627:therapeutic use*; D012074:Remission Induction; D016896:Treatment Outcome; D014839:Vomiting / Q000139:chemically induced
chemical_list: D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D000077237:Arsenic Trioxide